Cocrystalization and simultaneous agglomeration using hot melt extrusion

Pharmaceutical Research

Volumn 27, Issue 12, 2010, Pages 2725-2733

  Paradkar, Anant ^a   Dhumal, Ravindra S ^a   Kelly, Adrian L ^a   York, Peter ^a   Coates, Phil D ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

Cocrystals; Hot melt extrusion; Ibuprofen; Thermo mechanical process

Indexed keywords

IBUPROFEN; NICOTINAMIDE; SOLVENT;

ARTICLE; CHEMICAL ANALYSIS; COCRYSTALLIZATION; CONTROLLED STUDY; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DESIGN; DRUG PURITY; DRUG RELEASE; DRUG SOLUBILITY; DRUG STRUCTURE; HOT MELT EXTRUSION; PARTICLE SIZE; PRIORITY JOURNAL; PROCESS TECHNOLOGY; SCANNING ELECTRON MICROSCOPY; SHEAR STRESS; TABLET COMPRESSION; TABLET MANUFACTURE; TEMPERATURE; X RAY POWDER DIFFRACTION;

CALORIMETRY, DIFFERENTIAL SCANNING; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CRYSTALLIZATION; HOT TEMPERATURE; MICROSCOPY, ELECTRON, SCANNING; PHARMACEUTICAL PREPARATIONS; SOLUBILITY; SPECTROPHOTOMETRY, ULTRAVIOLET; X-RAY DIFFRACTION;

EID: 78651333999     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-010-0273-9     Document Type: Article

References (38)

1. Trask AV, Motherwell WD, Jones W. Physical stability enhancement of theophylline via cocrystallization. Int J Pharm. 2006;320:114-23.
2. Aakeroy CB, Forbes S, Desper J. Using cocrystals to systematically modulate aqueous solubility and melting behavior of an anticancer drug. J Am Chem Soc. 2009;131:17048-9.
3. Good DJ, Rodriguez-Hornedo N. Solubility advantage of pharmaceutical cocrystals. Cryst Growth Des. 2009;9:2252-64.
4. Remenar JF, Morissette SL, Peterson ML, Moulton B, MacPhee JM, Guzman HR, et al. Crystal engineering of novel cocrystals of a triazole drug with 1, 4-dicarboxylic acids. J Am Chem Soc. 2003;125:8456-7.
5. McNamara DP, Childs SL, Giordano J, Iarriccio A, Cassidy J, Shet MS, et al. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API. Pharm Res. 2006;23:1888-97.
6. Karki S, Friscic T, Laszlo F, Laity PR, Day GM, Jones W. Improving mechanical properties of crystalline solids by cocrystal formation: New compressible forms of paracetamol. Adv Mater. 2009;21:3905-9.
7. Sun CC, Hou H. Improving mechanical properties of caffeine and methyl gallate crystals by cocrystallization. Cryst Growth Des. 2008;8:1575-9.
8. Weyna DR, Shattock T, Vishweshwar P, Zaworotko MJ. Synthesis and structural characterization of cocrystals and pharmaceutical cocrystals: Mechanochemistry vs slow evaporation from solution. Cryst Growth Des. 2009;9:1106-23.
9. Hickey MB, Peterson ML, Scoppettuolo LA, Morrisette SL, Vetter A, Guzmán H, et al. Performance comparison of a cocrystal of carbamazepine with marketed product. Eur J Pharm Biopharm. 2007;67:112-9.
10. Trask AV, van de Streek J, Motherwell WDS, Jones W. Achieving polymorphic and stoichiometric diversity in cocrystal formation: Importance of solid-state grinding, powder x-ray structure determination, and seeding. Cryst Growth Des. 2005;5:2233-41.
11. Trask AV, Motherwell WDS, Jones W. Pharmaceutical cocrystallization: Engineering a remedy for caffeine hydration. Cryst Growth Des. 2005;5:1013-21.
12. Takata N, Shiraki K, Takano R, Hayashi Y, Terada K. Cocrystal screening of stanolone and mestanolone using slurry crystallization. Cryst Growth Des. 2008;8:3032-7.
13. Childs SL, Mougin P. Screening for solid forms by ultrasound crystallization and cocrystallization using ultrasound. WO. 2005;089375:A2.
14. Aher S, Dhumal RS, Mahadik KR, Paradkar AR, York P. Ultrasound assisted cocrystallization from solution (USSC) containing a non-congruently soluble cocrystal component pair: Caffeine/maleic acid. Eur J Pharm Sci. 2010;In Press, Accepted manuscript. doi:10.1016/j.ejps.2010.08.012.
15. Kuroda R, Imai Y, Tajima N. Generation of a co-crystal phase with novel coloristic properties via solid state grinding procedures. Chem Commun (Camb). 2002;23:2848-9.
16. Rastogi RP, Bassi PS, Chadha SL. Mechanism of the reaction between hydrocarbons and picric acid in the solid state. J Phys Chem. 1963;67:2569-73.
17. Rothenberg G, Downie AP, Raston CL, Scott JL. Understanding solid/solid organic reactions. J Am Chem Soc. 2001;123:8701-8.
18. Chadwick K, Davey R, Cross W. How does grinding produce cocrystals? Insights fromthe case of benzophenone and diphenylamine. Cryst Eng Comm. 2007;9:732-4.
19. Shan N, Toda F, Jones W. Mechanochemistry and co-crystal formation: Effect of solvent on reaction kinetics. Chem Commun. 2002;20:2372-3.
20. Schultheiss N, Newman A. Pharmaceutical cocrystals and their physicochemical properties. Cryst Growth Des. 2009;9:2950-67.
21. Sheikh AY, Rahim SA, Hammond RB, Roberts KJ. Scalable solution cocrystallization: Case of carbamazepine-nicotinamide I. Cryst Eng Comm. 2009;11:501-9.
22. Mazen H, Townend N. Method of creating crystalline substances. US. 2008;0280858:A1.
23. Padrela L, Rodrigues MA, Velaga SP, Fernandes AC, Matos HA, de Azevedo EG. Screening for pharmaceutical cocrystals using the supercritical fluid enhanced atomization process. J Supercrit Fluid. 2010;53:156-64.
24. Paradkar AR, Kelly AL, Coates PD, York P. Method and product. WO. 2010;013035:A1.
25. Medina C, Daurio D, Nagapudi K, Alvarez-Nunez F.Manufacture of pharmaceutical co-crystals using twin screw extrusion: A solvent-less and scalable process. J Pharm Sci. 2010;99:1693-6.
26. Crowley MM, Zhang F, Repka MA, Thumma S, Upadhye SB, Battu SK, et al. Pharmaceutical applications of hot-melt extrusion: Part I. Drug Dev Ind Pharm. 2007;33:909-26. (Pubitemid 47463803)
27. Repka MA, Battu SK, Upadhye SB, Thumma S, Crowley MM, Zhang F, et al. Pharmaceutical applications of hot-melt extrusion: Part II. Drug Dev Ind Pharm. 2007;33:1043-57. (Pubitemid 350034836)
28. Berry DJ, Seaton CC, Clegg W, Harrington RW, Coles SJ, Horton PN, et al. Applying hot-stage microscopy to co-crystal screening: A study of nicotinamide with seven active pharmaceutical ingredients. Cryst Growth Des. 2008;8:1697-712.
29. Lu E, Rodriguez-Hornedo N, Suryanarayanan R. A rapid thermal method for cocrystal screening. Cryst Eng Comm. 2008;10:665-8.
30. Melo TFA, Canevarolo SV. An optical device to measure in-line residence time distribution curves during extrusion. Poly Eng Sci. 2002;42:170-81.
31. Wostheinrich K, Schmidt PC. Polymorphic changes of thiamine hydrochloride during granulation and tableting. Drug Dev Ind Pharm. 2001;27:481-9.
32. Sun C, Grant D. Improved tableting properties of p-hydroxybenzoic acid by water of crystallization: A molecular insight. Pharm Res. 2004;21:382-6.
33. Maheshwari M, Ketkar AR, Chauhan B, Patil VB, Paradkar AR. Preparation and characterization of ibuprofen-cetyl alcohol beads by melt solidification technique: Effect of variables. Int J Pharm. 2003;261:57-67.
34. Dhumal RS, Shimpi SL, Chauhan B, Mahadik KR, Paradkar AR. Evaluation of a drug with wax-like properties as a melt binder. Acta Pharm. 2006;56:451-61.
35. Romero AJ, Grady LT, Rhodes CT. Dissolution testing of ibuprofen tablets. Drug Dev Ind Pharm. 1988;14:1549-86.
36. Stead JA, Freeman M, John EG, Ward GT, Whiting B. Ibuprofen tablets: Dissolution and bioavailability studies. Int J Pharm. 1983;14:59-72.
37. Oberoi LM, Alexander KS, Riga AT. Study of interaction between ibuprofen and nicotinamide using differential scanning calorimetry, spectroscopy, and microscopy and formulation of a fast-acting and possibly better ibuprofen suspension for osteoarthritis patients. J Pharm Sci. 2005;94:93-101.
38. Van Melkebeke B, Vermeulen B, Vervaet C, Remon JP. Melt granulation using a twin-screw extruder: A case study. Int J Pharm. 2006;326:89-93.